Contrast Media Injectors Market is expected to reach US$ 3 Billion by 2033 | FMI

 The market value of the Total Contrast Media Injectors to be sold this year, 2023, is around US$ 1.6 Billion. Furthermore, the global Contrast Media Injectors Market is predicted to reach approximately US$ 3 Billion by 2033 by following a yearly growth rate of 6.6%.


The global increase in trauma cases is expected to drive the growth of the contrast media injectors market. Furthermore, the rising prevalence of cancer among the world's geriatric population is expected to drive demand for contrast media injectors.

Get Full Access: https://www.futuremarketinsights.com/reports/contrast-media-injectors-market

Furthermore, as the number of cancer, neurological, and cardiovascular patients admitted to hospitals rises, the industry will experience significant growth. With the vast range of applications in radiology, interventional radiology, and interventional cardiology, hospitals are the principal users of high-pressure contrast media injectors.

End-user demand for technologically improved contrast media injectors, such as IT-enabled contrast media injectors that can connect to a hospital database for dosage monitoring, is driving up contrast media injector prices.

Air emboli formed during contrast media injection can restrict right ventricular outflow or clog pulmonary arterioles, resulting in significant complications such as cardiovascular collapse.

Key Takeaways from the Contrast Media Injectors Market Study Report

The United States is the leading market with a market share of 32.5%, which is around US$ 500 Mn in 2023. The demand for contrast media injectors in the country is projected to grow at a rate of 6.8% from 2023 to 2033.

In Europe, Germany is the dominant market and is projected to register a CAGR of 6.3% from 2023 to 2033. It is the second-largest market in the world and is predicted to reach US$ 202.9 Mn by the end of 2033.

While. the demand for contrast media injectors in the United Kingdom is growing faster than in Germany. The report predicts the growth rate for the UK market to be 6.4% through 2033 to reach a valuation of US$ 123.3 Mn.

Meanwhile, China is the fastest-growing region in the production and sales of contrast media injectors around the world. By registering a CAGR of 7.8% over the forecast years, this regional market is estimated to reach US$ 192.3 Mn by 2033.

India is emerging as a promising market with growing demand for contrast media injectors. The growth rate estimated for this regional market is around 5.4%, and the net worth of the market is to reach US$ 42.5 Mn by 2033.

Among the different types of contrast media injectors available in the market, CT injectors are the top-performing product type segment. This segment is projected to grow at a rate of 6.4% during the time period covering 2023 to 2033.

For the contrast media injectors market players, the hospital segment is predicted to remain the prominent end-user vertical. During the forecast period, this segment is expected to witness a year-on-year growth rate of 6.7% from 2023 to 2033.

Competitive Landscape for the Contrast Media Injectors Market

  • Mallinckrodt (Guerbet SA)
  • GE Healthcare
  • Bayer AG
  • Ulrich GmbH & Co. KG
  • Bracco Imaging S.p.A
  • Medtron
  • NemotoKyorindo Co. Ltd
  • Shenzhen Anke High-tech Co. Ltd
  • Sino Medical-device Technology Co., Ltd
  • Apollo RT Co., Ltd

Recent Developments in the Contrast Media Injectors Industry

  • In May 2021, Bayer AG announced a collaboration with ArcherDX, Inc., which will focus on the global development and commercialization of therapy-accompanying diagnostic tests – also known as companion diagnostics (CDx) – for Vitrakvi™ (larotrectinib), based on next-generation sequencing.
  • In May 2019, Ulrich’s CT contrast agent injector, CT motion, was made available in the world's most important medical technology market, the U.S.

Contrast Media Injectors Market by Category

By Product Type:

  • CT Injectors
  • MRI Injectors
  • Cardio Injectors

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostics Centers
  • Others

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more